uTRACT Jelmtyo® Registry
- Sponsor:
- UroGen Pharma, Inc.
- Sponsor Study ID:
- PRO00132320
- CTO #:
- 103857
- NCT Number:
- NCT05874921
- Phase:
- N/A
- Protocol Type:
- Supportive Care
- Age Group:
- Adults
- Disease Sites:
- Study Objectives:
- The primary objective of the registry is to study the use and impact of Jelmyto in patients with UTUC in clinical practice in the U.S.
- eConsent:
- Not available
- Study Documents:
-
Open Study Documents
(MUSC NetID required for document access)
For more information about this trial please contact the study team:
-
Medical University of South Carolina
- Principal Investigator, Tanneru, Karthik, at tanneru@musc.edu .
- Study Coordinator, Robinson, Patricia, at robinpat@musc.edu .
Trial opened at the following institutions:
Medical University of South Carolina